Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine vs Milrinone in Pediatric Low Cardiac Output
NCT05999487Unknown
- Sponsor
- Cairo University
- Start
- Oct 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in low cardiac output syndrome (LCOS) comparing Milrinone with Dobutamine (2 arms). Primary endpoint: Time to achievement of therapeutic endpoints for hemodynamics at 24 hours. Status: unknown.
02
Drugs
milrinonedobutamine
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on NCT05999487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05999487.